FDA propose drug label changes for use in pregnancy

被引：0

作者：

机构：

来源：

Reactions Weekly | 2008年 / 1205卷 / 1期

关键词：

Pregnant Woman; Potential Risk; Healthcare Professional; Prescription Medication; Biological Product;

D O I：

10.2165/00128415-200812050-00001

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 1

共 50 条

[1] Changes at FDA may speed drug approval process and increase off-label use
Reh, M
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11) : 805 - 807
[2] INDUSTRY ASKS FDA TO DITCH CHANGES TO DRUG-LABEL RULES
不详
CHEMICAL & ENGINEERING NEWS, 2015, 93 (18) : 22 - 22
[3] Evaluation of FDA safety-related drug label changes in 2010
Lester, Jean
Neyarapally, George A.
Lipowski, Earlene
Graham, Cheryl Fossum
Hall, Marni
Dal Pan, Gerald
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (03) : 302 - 305
[4] Regulating off-label drug use - Rethinking the role of the FDA
Stafford, Randall S.
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1427 - 1429
[5] FDA narrows drug label usage
Elie Dolgin
Nature, 2009, 460 : 1069 - 1069
[6] FDA narrows drug label usage
Dolgin, Elie
NATURE, 2009, 460 (7259) : 1069 - 1069
[7] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
Tanne, Janice Hopkins
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
[8] Medication Use During Pregnancy and Lactation The New FDA Drug Labeling
Tillett, Jackie
JOURNAL OF PERINATAL & NEONATAL NURSING, 2015, 29 (02) : 97 - 99
[9] ‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use
W A Meadows
B D Hollowell
International Journal of Impotence Research, 2008, 20 : 135 - 144
[10] 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use
Meadows, W. A.
Hollowell, B. D.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (02) : 135 - 144

← 1 2 3 4 5 →